Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hervé Broly, Jonathan Souquet & Alain Beck. (2023) Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins. mAbs 15:1.
Read now
Read now
Jianlin Xu, Xuankuo Xu, Chao Huang, James Angelo, Christopher L. Oliveira, Mengmeng Xu, Xia Xu, Deniz Temel, Julia Ding, Sanchayita Ghose, Michael C. Borys & Zheng Jian Li. (2020) Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study. mAbs 12:1.
Read now
Read now
Articles from other publishers (18)
Seo‐Young Park, Dong‐Hyuk Choi, Jinsung Song, Uiseon Park, Hyeran Cho, Bee Hak Hong, Yaron R. Silberberg & Dong‐Yup Lee. (2023) Debottlenecking and reformulating feed media for improved CHO cell growth and titer by data‐driven and model‐guided analyses. Biotechnology Journal 18:12.
Crossref
Crossref
Corey Kretzmer, Kelsey Reger, Vincent Balassi, Quang Long Pham, Michael Johns, Samuel T. Peters, Amber Petersen, Jana Mahadevan, Jason Gustin, Trissa Borgschulte & David Razafsky. (2023) Chemical and Genetic Modulation of Complex I of the Electron Transport Chain Enhances the Biotherapeutic Protein Production Capacity of CHO Cells. Cells 12:22, pages 2661.
Crossref
Crossref
Sadegh Shojaei Baghini, Ehsan Razeghian, Setare Kakavand Malayer, Renzon Daniel Cosme Pecho, Mohammed Obaid, Zinah Salem Awfi, H.A. Zainab & Mehdi Shamsara. (2023) Recent advances in the application of genetic and epigenetic modalities in the improvement of antibody-producing cell lines. International Immunopharmacology 123, pages 110724.
Crossref
Crossref
Witsanu Srila, Martina Baumann, Markus Riedl, Kuntalee Rangnoi, Nicole Borth & Montarop Yamabhai. (2023) Glutamine synthetase (GS) knockout (KO) using CRISPR/Cpf1 diversely enhances selection efficiency of CHO cells expressing therapeutic antibodies. Scientific Reports 13:1.
Crossref
Crossref
Stephen Goldrick, Haneen Alosert, Clare Lovelady, Nicholas J. Bond, Tarik Senussi, Diane Hatton, John Klein, Matthew Cheeks, Richard Turner, James Savery & Suzanne S. Farid. (2023) Next-generation cell line selection methodology leveraging data lakes, natural language generation and advanced data analytics. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Lucie Grindes, Camille Florimond, Sébastien Ribault, Céline Raymond, Wilfrid Dieryck, Gilles Joucla & Cyrielle Corbin. (2023) Weak promoters to drive selection marker expression: Improvement of cell line development process for therapeutic protein production in CHO-K1 cells. Journal of Biotechnology 369, pages 43-54.
Crossref
Crossref
Jianlin Xu, Johanna Santos, Nadine S. Anderson, Michael C. Borys, Girish Pendse & Zheng Jian Li. (2022)
Antibody charge variant modulation by in vitro enzymatic treatment in different
Chinese hamster ovary
cell cultures
. Biotechnology Progress 38:5.
Crossref
Crossref
Sarah A. Sacco, Angela M. Tuckowski, Irina Trenary, Lauren Kraft, Michael J. Betenbaugh, Jamey D. Young & Kevin D. Smith. (2022) Attenuation of glutamine synthetase selection marker improves product titer and reduces glutamine overflow in Chinese hamster ovary cells. Biotechnology and Bioengineering 119:7, pages 1712-1727.
Crossref
Crossref
Wenwen Yang, Junhe Zhang, Yunxi Xiao, Wenqing Li & Tianyun Wang. (2022) Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Qin He, Matthew S. Rehmann, Jun Tian, Jianlin Xu, Luzmary Sabino, Erik Vandermark, Ziev Basson, Iris Po, Kathleen Bierilo, Gabi Tremml, Giovanni Rizzi, Erik F. Langsdorf, Nan-Xin Qian, Michael C. Borys, Anurag Khetan & Zheng-Jian Li. (2022) Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning. Bioengineering 9:4, pages 173.
Crossref
Crossref
Jun-He Zhang, Lin-Lin Shan, Fan Liang, Chen-Yang Du & Jing-Jing Li. (2022) Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Benno Verbelen, Tiziana Girardi, Sergey O. Sulima, Stijn Vereecke, Paulien Verstraete, Jelle Verbeeck, Jonathan Royaert, Sonia Cinque, Lorenzo Montanaro, Marianna Penzo, Maya Imbrechts, Nick Geukens, Thomas Geuens, Koen Dierckx, Daniele Pepe, Kim Kampen & Kim De Keersmaecker. (2022) Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells. Engineering in Life Sciences 22:2, pages 100-114.
Crossref
Crossref
Sudeepa Rajan, Aadil Hussain Bhat, Sudipa Maity & Omika Thakur. 2022. Fundamentals and Advances in Medical Biotechnology. Fundamentals and Advances in Medical Biotechnology
93
128
.
Julia Kronenberg, Katrin Schrödter, Gundula A. Noll, Richard M. Twyman, Dirk Prüfer & Philip Känel. (2021) The tobacco phosphatidylethanolamine‐binding protein NtFT4 simultaneously improves vitality, growth, and protein yield in human cells. Biotechnology and Bioengineering 118:10, pages 3770-3786.
Crossref
Crossref
Steven C. Huhn, Yang Ou, Xiaoyan Tang, Bo Jiang, Ren Liu, Henry Lin & Zhimei Du. (2021)
Improvement of the efficiency and quality in developing a new
CHO
host cell line
. Biotechnology Progress 37:5.
Crossref
Crossref
Jonathan A. Arnesen, Jakob Blæsbjerg Hoof, Helene Faustrup Kildegaard & Irina Borodina. 2021. Metabolic Engineering. Metabolic Engineering
301
337
.
Alessandro T. Caputo, Oliver M. Eder, Hana Bereznakova, Heleen Pothuis, Albert Ardevol, Janet Newman, Stewart Nuttall, Thomas S. Peat & Timothy E. Adams. (2021) Structure-guided selection of puromycin N-acetyltransferase mutants with enhanced selection stringency for deriving mammalian cell lines expressing recombinant proteins. Scientific Reports 11:1.
Crossref
Crossref
Jianlin Xu, Matthew S. Rehmann, Mengmeng Xu, Shun Zheng, Charles Hill, Qin He, Michael C. Borys & Zheng Jian Li. (2020) Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturing. Bioresources and Bioprocessing 7:1.
Crossref
Crossref